Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

ENLIVEN MARKETING TECHNOLOGIES CORP (ENLV) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $6.49 Metrics
OS: 67.7 M -59 % ROE
Market cap: $439 M -56 % ROIC
Net cash: $1.25 M $0.02 per share
EV: $438 M

 
TTM Valuation
EBITDA ($8.2) M
EBIT ($12.1) M
EPS ($114.87)

Recent News + Filings   (All items)
Date FiledTypeDescription
03/22/2021 GN Enlivex Announces Research Collaboration with Yale Cancer Center to Assess Synergistic Effect of Allocetra™ in Combination with Immune Checkpoint Inhibitors
03/09/2021 GN Enlivex Announces Upcoming Virtual Investor Conference Participations
03/01/2021 GN Enlivex and Mount Sinai Health System Announce Research Collaboration for the Development of Allocetra in Combination with Immune Checkpoint Inhibitors
02/16/2021 GN Enlivex Announces Issuance of New U.S. Patent Covering Methods of Treating Gout, Inflammatory Bowel Disease, Crohn's Disease, Ulcerative Colitis and GvHD...
02/12/2021 GN Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
02/09/2021 GN Enlivex Increases Previously Announced Bought Deal Offering to Approximately $46.0 Million of Ordinary Shares
02/09/2021 GN Enlivex Announces $10 Million Bought Deal Offering of Ordinary Shares


Financial Summary   (All financials)
In millions, except per share itemsDec-31-07Dec-31-06Dec-31-05Dec-31-04Dec-31-03Dec-31-02Dec-31-01Dec-31-00
Revenues18.717.225.314.513.518.114.03.6
            Revenue growth9.0%-32.1%74.1%7.4%-25.4%29.5%291.3% 
Cost of goods sold9.16.77.63.55.93.93.61.5
Gross profit9.710.517.711.17.714.210.42.0
            Gross margin51.6%61.1%70.1%76.2%56.6%78.3%74.4%56.9%
Sales and marketing4.75.95.13.78.716.717.518.6
Research and development3.33.94.53.44.24.39.810.6
General and administrative9.38.510.17.211.510.3  
EBITA-8.2-8.2-2.6-4.0-18.4-19.1-29.2-60.1
            EBITA margin-43.9%-48.0%-10.1%-27.3%-135.8%-105.4%-208.3%-1678.0%
Amortization of intangibles1.40.60.50.00.00.717.53.0
EBIT-9.6-8.8-3.1-4.0-18.4-19.8-46.6-63.1
            EBIT margin-51.3%-51.3%-12.1%-27.4%-135.8%-109.1%-332.9%-1762.5%
Pre-tax income-13.5-19.6-10.7-9.7-21.6-25.9-53.5-61.9
Income taxes0.10.10.10.10.10.10.00.0
            Tax rate      0.0%0.0%
Net income-13.5-19.7-10.6-9.7-21.5-25.9-52.4-56.0
            Net margin-72.2%-114.8%-41.9%-66.7%-158.9%-142.7%-373.9%-1563.0%
 
Diluted EPS($167.42)($295.98)($183.13)($185.61)($478.33)($638.39)($1,340.17)($2,000.56)
Shares outstanding (diluted)0.10.10.10.10.00.00.00.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy